Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Intraarrest transport, extracorporeal cardiopulmonary resuscitation, and early invasive management in refractory out-of-hospital cardiac arrest: an individual patient data pooled analysis of two randomised trials

J. Belohlavek, D. Yannopoulos, J. Smalcova, D. Rob, J. Bartos, M. Huptych, P. Kavalkova, R. Kalra, B. Grunau, FS. Taccone, TP. Aufderheide

. 2023 ; 59 (-) : 101988. [pub] 20230505

Status neindexováno Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009825

BACKGROUND: Refractory out-of-hospital cardiac arrest (OHCA) treated with standard advanced cardiac life support (ACLS) has poor outcomes. Transport to hospital followed by in-hospital extracorporeal cardiopulmonary resuscitation (ECPR) initiation may improve outcomes. We performed a pooled individual patient data analysis of two randomised controlled trials evaluating ECPR based approach in OHCA. METHODS: The individual patient data from two published randomised controlled trials (RCTs) were pooled: ARREST (enrolled Aug 2019-June 2020; NCT03880565) and PRAGUE-OHCA (enrolled March 1, 2013-Oct 25, 2020; NCT01511666). Both trials enrolled patients with refractory OHCA and compared: intra-arrest transport with in-hospital ECPR initiation (invasive approach) versus continued standard ACLS. The primary outcome was 180-day survival with favourable neurological outcome (defined as Cerebral Performance Category 1-2). Secondary outcomes included: cumulative survival at 180 days, 30-day favourable neurological survival, and 30-day cardiac recovery. Risk of bias in each trial was assessed by two independent reviewers using the Cochrane risk-of-bias tool. Heterogeneity was assessed via Forest plots. FINDINGS: The two RCTs included 286 patients. Of those randomised to the invasive (n = 147) and standard (n = 139) groups, respectively: the median age was 57 (IQR 47-65) and 58 years (IQR 48-66), and the median duration of resuscitation was 58 (IQR 43-69) and 49 (IQR 33-71) minutes (p = 0.17). In a modified intention to treat analysis, 45 (32.4%) in the invasive and 29 (19.7%) patients in the standard arm survived to 180 days with a favourable neurological outcome [absolute difference (AD), 95% CI: 12.7%, 2.6-22.7%, p = 0.015]. Forty-seven (33.8%) and 33 (22.4%) patients survived to 180 days [HR 0.59 (0.43-0.81); log rank test p = 0.0009]. At 30 days, 44 (31.7%) and 24 (16.3%) patients had favourable neurological outcome (AD 15.4%, 5.6-25.1%, p = 0.003), 60 (43.2%), and 46 (31.3%) patients had cardiac recovery (AD: 11.9%, 0.7-23%, p = 0.05), in the invasive and standard arms, respectively. The effect was larger in patients presenting with shockable rhythms (AD 18.8%, 7.6-29.4; p = 0.01; HR 2.26 [1.23-4.15]; p = 0.009) and prolonged CPR (>45 min; HR 3.99 (1.54-10.35); p = 0.005). INTERPRETATION: In patients with refractory OHCA, the invasive approach significantly improved 30- and 180-day neurologically favourable survival. FUNDING: None.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009825
003      
CZ-PrNML
005      
20230721095439.0
007      
ta
008      
230707s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.eclinm.2023.101988 $2 doi
035    __
$a (PubMed)37197707
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Belohlavek, Jan $u 2 Department of Medicine - Department of Cardiovascular Medicine, General University Hospital and 1 Faculty of Medicine, Charles University in Prague, Czech Republic
245    10
$a Intraarrest transport, extracorporeal cardiopulmonary resuscitation, and early invasive management in refractory out-of-hospital cardiac arrest: an individual patient data pooled analysis of two randomised trials / $c J. Belohlavek, D. Yannopoulos, J. Smalcova, D. Rob, J. Bartos, M. Huptych, P. Kavalkova, R. Kalra, B. Grunau, FS. Taccone, TP. Aufderheide
520    9_
$a BACKGROUND: Refractory out-of-hospital cardiac arrest (OHCA) treated with standard advanced cardiac life support (ACLS) has poor outcomes. Transport to hospital followed by in-hospital extracorporeal cardiopulmonary resuscitation (ECPR) initiation may improve outcomes. We performed a pooled individual patient data analysis of two randomised controlled trials evaluating ECPR based approach in OHCA. METHODS: The individual patient data from two published randomised controlled trials (RCTs) were pooled: ARREST (enrolled Aug 2019-June 2020; NCT03880565) and PRAGUE-OHCA (enrolled March 1, 2013-Oct 25, 2020; NCT01511666). Both trials enrolled patients with refractory OHCA and compared: intra-arrest transport with in-hospital ECPR initiation (invasive approach) versus continued standard ACLS. The primary outcome was 180-day survival with favourable neurological outcome (defined as Cerebral Performance Category 1-2). Secondary outcomes included: cumulative survival at 180 days, 30-day favourable neurological survival, and 30-day cardiac recovery. Risk of bias in each trial was assessed by two independent reviewers using the Cochrane risk-of-bias tool. Heterogeneity was assessed via Forest plots. FINDINGS: The two RCTs included 286 patients. Of those randomised to the invasive (n = 147) and standard (n = 139) groups, respectively: the median age was 57 (IQR 47-65) and 58 years (IQR 48-66), and the median duration of resuscitation was 58 (IQR 43-69) and 49 (IQR 33-71) minutes (p = 0.17). In a modified intention to treat analysis, 45 (32.4%) in the invasive and 29 (19.7%) patients in the standard arm survived to 180 days with a favourable neurological outcome [absolute difference (AD), 95% CI: 12.7%, 2.6-22.7%, p = 0.015]. Forty-seven (33.8%) and 33 (22.4%) patients survived to 180 days [HR 0.59 (0.43-0.81); log rank test p = 0.0009]. At 30 days, 44 (31.7%) and 24 (16.3%) patients had favourable neurological outcome (AD 15.4%, 5.6-25.1%, p = 0.003), 60 (43.2%), and 46 (31.3%) patients had cardiac recovery (AD: 11.9%, 0.7-23%, p = 0.05), in the invasive and standard arms, respectively. The effect was larger in patients presenting with shockable rhythms (AD 18.8%, 7.6-29.4; p = 0.01; HR 2.26 [1.23-4.15]; p = 0.009) and prolonged CPR (>45 min; HR 3.99 (1.54-10.35); p = 0.005). INTERPRETATION: In patients with refractory OHCA, the invasive approach significantly improved 30- and 180-day neurologically favourable survival. FUNDING: None.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Yannopoulos, Demetris $u Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
700    1_
$a Smalcova, Jana $u 2 Department of Medicine - Department of Cardiovascular Medicine, General University Hospital and 1 Faculty of Medicine, Charles University in Prague, Czech Republic
700    1_
$a Rob, Daniel $u 2 Department of Medicine - Department of Cardiovascular Medicine, General University Hospital and 1 Faculty of Medicine, Charles University in Prague, Czech Republic
700    1_
$a Bartos, Jason $u Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
700    1_
$a Huptych, Michal $u Czech Institute of Informatics, Robotics and Cybernetics (CIIRC), Czech Technical University in Prague, Czech Republic
700    1_
$a Kavalkova, Petra $u 2 Department of Medicine - Department of Cardiovascular Medicine, General University Hospital and 1 Faculty of Medicine, Charles University in Prague, Czech Republic
700    1_
$a Kalra, Rajat $u Center for Resuscitation Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
700    1_
$a Grunau, Brian $u Department of Emergency Medicine, St Paul's Hospital, and University of British Columbia, 1081 Burrard St, Vancouver, BC, Canada
700    1_
$a Taccone, Fabio Silvio $u Department of Intensive Care, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Route de Lennik 808, Brussels 1070, Belgium
700    1_
$a Aufderheide, Tom P $u Department of Emergency Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
773    0_
$w MED00200566 $t EClinicalMedicine $x 2589-5370 $g Roč. 59, č. - (2023), s. 101988
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37197707 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095432 $b ABA008
999    __
$a ok $b bmc $g 1958518 $s 1196089
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 59 $c - $d 101988 $e 20230505 $i 2589-5370 $m EClinicalMedicine $n EClinicalMedicine $x MED00200566
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...